China’s Kangtai gets approval for clinical trial of coronavirus vaccine candidate

China’s Shenzhen Kangtai Biological Products said on Tuesday it planned to launch a clinical trial of its coronavirus vaccine candidate as soon as possible after it had obtained regulatory approval …
( read original story …)